# PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide

- Link: https://www.thailand-business-news.com/pr-news/pentax-medical-and-magentiq-eye-expand-global-partnership-to-advance-ai-assisted-colonoscopy-worldwide
- Published: 2026-08-26T19:00:00+07:00
- Author: PR Newswire

**_Expanded agreement combines PENTAX Medical’s continued investment in flexible
reusable endoscopy with MAGENTIQ’s clinically validated AI capabilities, expanding
access to AI-assisted colonoscopy across USA, EMEA, JAPAC and LATAM._**

TOKYO, Aug. 26, 2026 /PRNewswire/ — PENTAX Medical, a HOYA Group company, today 
announced the expansion of its partnership with MAGENTIQ EYE, extending an agreement
that initially covered the United States to include EMEA, JAPAC and LATAM, further
advancing access to AI-enabled endoscopy worldwide. Under the expanded agreement,
MAGENTIQ-COLO™ will be integrated into PENTAX Medical’s INSPIRA™ EPK-i8020c Video
Processor and PENTAX Medical’s IMAGINA™ EPK-i5500c Video Processor.

PENTAX Medical will market, distribute and support the integrated AI solution across
the United States, EMEA, JAPAC and LATAM, expanding access to clinically validated
AI-assisted colonoscopy across these markets, supporting endoscopists in delivering
high-quality care across those markets.

PENTAX Medical’s INSPIRA™ and IMAGINA™ combine advanced imaging performance with
high-quality visualization across a broad range of endoscopic procedures. By integrating
MAGENTIQ-COLO™, physicians can combine advanced endoscopic imaging with a clinically
validated AI solution for real-time polyp detection, together with additional AI
capabilities for diagnostics, procedural quality support, and a seamless workflow
designed to help deliver more consistent, high-quality colonoscopy in everyday clinical
practice

MAGENTIQ-COLO™’s performance has been validated in a large multicenter randomized
clinical trial published in The Lancet Digital Health, demonstrating a 26% relative
increase in adenoma detection rate (ADR) and a 48% relative decrease in adenoma 
miss rate (AMR) compared with standard colonoscopy.

The expanded agreement reflects MAGENTIQ EYE’s and PENTAX Medical’s shared commitment
to advancing the quality of colonoscopy through integrated AI solutions that support
endoscopists in everyday clinical practice.

_"At PENTAX Medical, we are committed to advancing flexible reusable endoscopy through
continued investment, innovation and strong clinical partnerships_," said **Dominique
Vincent, Global President, PENTAX Medical**. "_Expanding our collaboration with 
MAGENTIQ EYE brings clinically validated AI capabilities to more physicians worldwide
and further reinforces our commitment to supporting endoscopists with solutions 
they can rely on every day, helping drive confidence, consistency and high-quality
care throughout everyday clinical practice."_

Building on this shared commitment, **Dror Zur, Founder and CEO of MAGENTIQ EYE**,
added: "_Expanding our collaboration with PENTAX Medical is an important step in
our global growth strategy. By bringing together trusted endoscopy platforms and
clinically validated AI, we are helping more physicians deliver consistently high-
quality colonoscopy_."

**About PENTAX Medical **

PENTAX Medical, a division of the HOYA Group, is a global player in flexible, reusable
endoscopy solutions. The company develops, manufactures, distributes, and services
endoscopic equipment worldwide. PENTAX Medical is committed to delivering intuitive,
flexible endoscopy solutions that empower healthcare professionals to provide outstanding
care. Its mission is to maintain product excellence while collaborating closely 
with clinical partners to understand and address their daily challenges, workflows,
and goals. At the core of this mission is a commitment to reliability and high-quality
imaging—fundamental requirements for clinical performance. Building on this foundation,
PENTAX Medical delivers solutions that integrate seamlessly into clinical practice,
supported by ergonomic and ease-of-use innovations, practical clinical education,
and personalized, attentive customer support.  
For more information, please visit
our website: [https://www.pentaxmedical.com](https://www.pentaxmedical.com/)

**About MAGENTIQ EYE**

MAGENTIQ EYE ([www.magentiq.com](http://www.magentiq.com)) is a medical device company
specializing in AI-powered decision support for gastrointestinal endoscopy. Its 
MAGENTIQ-COLO™ platform integrates computer-aided detection (CADe), computer-aided
diagnosis (CADx) and computer-aided quality indicator measurements (CAQ) capabilities
to enhance detection and diagnostic performance, support procedural quality metrics,
and enable structured reporting in colonoscopy. MAGENTIQ-COLO™ includes FDA-cleared
and CE-marked features, with additional CE-marked CADx and CAQ capabilities available
in Europe.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide ](http://www.prnasia.com/story/archive/5032960_CN32960_0?rand=184833)